Inventor
Glenn Dorin
Inventor
San Rafael, CA, US
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides39%
A61KPreparations for medical, dental or toiletry purposes11%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for9%
A23PShaping or working of foodstuffs, not fully covered by a single other subclass9%
C12NMicroorganisms or enzymes9%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
7,851,433'Method of purifying TFPI and TFPI analogs'20107,226,757'Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor'20077,193,042'Methods for purifying authentic IGF from yeast hosts'20077,071,313'Methods of purifying authentic IGF from yeast hosts'20067,022,672'Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor'20066,756,484'IGF-I purification process'20046,323,326'Method of solubilizing, purifying, and refolding protein'20016,319,896'Method of solubilizing, purifying, and refolding protein'20016,117,983'Methods for purifying authentic IGF from yeast hosts'20006,033,875'Method of improved production of insulin-like growth factor'20005,814,485'Production of interferon-.beta. (IFN-.beta.) in E. coli'19985,466,781'Process for purifying bacterially produced M-CSF'19955,248,769'Process for recovering refractile bodies containing heterologous proteins from microbial hosts'19935,162,507'Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms'19924,894,439'N-terminal derivatives of tumor necrosis factor purified by microporous PTFE membranes'19904,894,334'Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria'19904,748,234'Process for recovering refractile bodies containing heterologous proteins from microbial hosts'19884,656,132'Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria'1987Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1987–1992Patents assigned to CETUS CORP (5)· patent assignee history
1987–2010Based in San Rafael, CA, US· patent location history
1998–2006Patents assigned to CHIRON CORP (7)· patent assignee history
2000–2007Based in San Bernardino, CA, US· patent location history
2001Patents assigned to SEARLE & CO (2)· patent assignee history
2004–2007Patents assigned to CEPHALON INC (2)· patent assignee history
2007–2010Patents assigned to NOVARTIS VACCINES & DIAGNOSTIC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CHIRON CORP | 7 | 1998–2006 |
| CETUS CORP | 5 | 1987–1992 |
| CEPHALON INC | 2 | 2004–2007 |
| NOVARTIS VACCINES & DIAGNOSTIC | 2 | 2007–2010 |
| SEARLE & CO | 2 | 2001 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Rafael, California, US | 16 | 1987–2010 |
| San Bernardino, California, US | 2 | 2000–2007 |